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AbstrACt
Introduction Loneliness and social isolation have been 
identified as significant public health concerns, but 
improving relationships and increasing social participation 
may improve health outcomes and quality of life. The aim 
of the Project About Loneliness and Social networks (PALS) 
study is to assess the effectiveness and cost-effectiveness 
of a guided social network intervention within a community 
setting among individuals experiencing loneliness and 
isolation and to understand implementation of Generating 
Engagement in Network Involvement (Genie) in the context 
of different organisations.
Methods and analysis The PALS trial will be a pragmatic, 
randomised controlled trial comparing participants 
receiving the Genie intervention to a wait-list control 
group. Eligible participants will be recruited from 
organisations working within a community setting: any 
adult identified as socially isolated or at-risk of loneliness 
and living in the community will be eligible. Genie will be 
delivered by trained facilitators recruited from community 
organisations. The primary outcome will be the difference 
in the SF-12 Mental Health composite scale score at 
6-month follow-up between the intervention and control 
group using a mixed effects model (accounting for 
clustering within facilitators and organisation). Secondary 
outcomes will be loneliness, social isolation, well-being, 
physical health and engagement with new activities. The 
economic evaluation will use a cost-utility approach, and 
adopt a public sector perspective to include health-related 
resource use and costs incurred by other public services. 
Exploratory analysis will use a societal perspective, and 
explore broader measures of benefit (capability well-
being). A qualitative process evaluation will explore 
organisational and environmental arrangements, as 
well as stakeholder and participant experiences of the 
study to understand the factors likely to influence future 
sustainability, implementation and scalability of using a 
social network intervention within this context.
Ethics and dissemination This study has received 
NHS ethical approval (REC reference: 18/SC/0245). The 
findings from PALS will be disseminated widely through 
peer-reviewed publications, conferences and workshops in 
collaboration with our community partners.
trial registration number ISRCTN19193075
IntroduCtIon
Social isolation is considered to be an objec-
tive lack of social connections, contact or 
participation, while loneliness is a subjective 
psychological state where there is a discrep-
ancy between desired and perceived levels 
of support or connectedness.1 2 The preva-
lence rates of loneliness and isolation vary;3 
however, it is estimated to affect about 30% 
of the adult population in the UK.4 Specific 
at-risk groups, such as the elderly, minority 
communities and those with long-term 
mental or physical health conditions are 
significantly more isolated than those in good 
health.3 5 6 The Office of National Statistics 
strengths and limitations of this study
 ► This study will evaluate an existing social network 
intervention (Genie,  Generating Engagement in 
Network Involvement) in the context of loneliness 
and social isolation.
 ► The Project About Loneliness and Social networks 
study consists of a pragmatic randomised controlled 
trial implemented in conjunction with communi-
ty-based stakeholders in a community setting in two 
areas of the UK.
 ► The process evaluation and analysis has been de-
signed to understand the factors influencing the 
implementation and scalability of social network 
interventions in this context.
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(ONS) recently identified three profiles of individuals 
who are ‘at-risk’; these suggest that different factors may 
be important in the experience of loneliness at different 
points across the life course.7 
the problem: health implications of loneliness and social 
isolation
The impact of loneliness and isolation on well-being 
and the associated health risks have been identified as a 
significant public health concern8 9 exacerbated by the 
prevalence of long-term conditions and advancing age.10 
Both loneliness and social isolation are associated with 
poor physical and mental health outcomes,11–13 reduced 
quality of life14 15 and is linked to poorer physiological 
outcomes such as raised blood pressure and increased 
health-risk behaviours (eg, sedentary behaviour).16 Their 
impact on mortality is estimated to exceed that of tradi-
tional risk factors such as obesity and cigarette smoking, 
with a 50% higher risk compared with socially integrated 
participants.17–19 There are also significant costs asso-
ciated with raised demand and use of health services, 
and loneliness is associated with increased general prac-
titioner (GP) appointments, emergency hospital admit-
tance and premature social care use.20–22
social relationships and preventing or reducing loneliness and 
social isolation
Although the determinants of loneliness and isolation are 
varied, social and emotional support from others is likely 
to be protective,23 with emerging evidence suggesting 
that improving the quality of interpersonal relationships 
and participation in social activities may be key to tack-
ling the impact of loneliness.9 Evidence has indicated that 
increasing social interactions and the number of people 
who can be relied on is associated with reduced levels of 
distress,24 while connecting with community resources 
can help protect against loneliness for those who are 
most at risk.9 25 Furthermore, there is evidence that social 
network interventions can significantly improve health 
outcomes, quality of life and increase the take-up of 
new activities.26 27 A diverse and supportive network has 
been shown to reduce health service costs.28 A recent 
The National Institute for Health and Care Excellence 
(NICE) quality standard recommends the navigation 
of older vulnerable people to community activities as a 
means of preventing loneliness in this group.25
rationale and risk benefits for the current trial
In line with this evidence, there is a logical argument 
for introducing an effective social network intervention 
outside of formal healthcare settings to connect people 
who are experiencing loneliness to others within their 
communities.25 Creative engagement with non-tradi-
tional informal providers of wellness management (such 
as through accessing locally available community groups) 
offers an alternative opportunity to address health and 
social needs. We envisage that the study will offset any 
burden through providing wider benefit to organisations; 
first through staff development and training integrating 
the intervention into practice, and, second, by providing 
a resource and alternative referral pathway for individuals 
who they have identified at risk of isolation or loneliness 
(potentially extending beyond the life of the study). A 
series of nestled qualitative process studies will examine 
the context, practices and processes relating to imple-
menting the intervention within the community context, 
and an economic evaluation to assess whether this is 
cost-effective.
study aims and research questions
The aim of the Project About Loneliness and Social 
networks (PALS) study is to assess the feasibility, accept-
ability, effectiveness and cost-effectiveness of a facilitated 
social network intervention compared with a wait-list 
control within a community setting among at-risk popu-
lations, and to understand the implementation in the 
context of different organisations who work in this 
environment. The Genie (Generating Engagement in 
Network Involvement) intervention is an online, facili-
tated, social networking tool designed to develop oppor-
tunities for social involvement.
Primary objectives
 ► To determine the effect of Genie compared with usual 
care on mental health (SF-12 composite scale score) 
at 3 and 6 months.
Secondary objectives
 ► To determine the effect of Genie compared with usual 
care on loneliness, social isolation, physical health 
and engagement with new activities at 3 and 6 months.
 ► To establish whether the use of Genie within a commu-
nity setting is cost-effective.
Process analysis objectives
 ► To assess the acceptability and feasibility of running 
the study based on recruitment and retention during 
an internal pilot phase.
 ► To explore the experiences of using Genie, how the 
intervention impacts on loneliness and isolation and 
the mechanisms by which participants enact change.
 ► To explore contextual environmental and organisa-
tional factors that inhibit or promote the integration, 
sustainability and scalability of Genie for addressing 
loneliness in local and organisational settings.
MEthods And AnAlysIs
study design and setting
We will conduct a pragmatic, randomised controlled 
trial comparing participants receiving the facilitated 
social network Genie intervention to a wait-list control 
group; randomisation will be at individual and/or 
cluster (facilitator) level (see Randomisation section). 
We will work closely with community partners two local-
ities (centred around Southampton and Liverpool) in 
identifying participants and delivering the interven-
tion, as well as informing our understanding of the 
challenges and environmental factors associated with 
implementation. Partners may include any group or 
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organisation that has the potential to identify or access 
at-risk individuals.
study participants
Identification
We will use a multistranded recruitment strategy to reflect 
the diversity of individuals who are living with loneliness 
or in isolation. This will be facilitated by collaborating 
community organisations to ensure that we are able to 
identify and access those most at-risk. Potential partici-
pants will be identified in the manner that best operates 
within existing working practices for each organisation 
(which will be different for each organisation/collabo-
rator). This is necessary to explore the integration and 
scalability of Genie in local and organisational settings. 
Potential participants will be invited by the organisation; 
this may be by letter or during routine visits, appoint-
ments, or in line with the usual working practices of the 
partner organisation. This may include (but is not limited 
to) new referrals, waiting lists or opportunistic contacts 
during routine work of partner organisation. All eligible 
participants will be given a research pack including an 
invitation letter, participant information sheet and free-
post reply slip to return should they wish to take part in 
the trial.
Eligibility criteria
We will recruit any adult (aged 18 or over) who is identi-
fied as being isolated or at risk of loneliness. We define 
a socially isolated person as one for whom there is an 
‘absence of social contacts or community involvement, or 
lack of access to services’ in line with the definition used 
by Hampshire County Council.29
Exclusion criteria
Exclusion criteria will include participants who are
 ► currently hospitalised (ie, not self-managing within a 
community setting),
 ► ,those in the end stages of life or any condition which 
impacts on ability to take part,
 ► those lacking sufficient capacity
 ► and those having previously used the Genie 
intervention.
Eligibility will be assessed by the community partners 
and confirmed by the research team in all cases.
randomisation
To overcome potential issues of contamination (where a 
facilitator could become familiar with how GENIE works 
and thus find out about local activities and advise control 
group participants), facilitators will be 1:1 randomised to 
either the intervention or control arm. Randomisation 
will be stratified by organisation in blocks of two (ie, one 
facilitator will be randomised to the intervention arm 
and one to the control arm) and carried out by the trial 
statistician (SE) using the statistical software R v3.5.1. In 
some organisations, the risk of contamination does not 
exist (eg, where the only contact between a facilitator and 
participants would be by delivering the intervention). 
In these cases, some efficiency is gained by randomising 
the participants individually (block randomised 1:1 to 
intervention and control, again stratifying by organisa-
tion). The summary below details the different scenarios. 
Preferred options (A&B) to be used whenever possible: 
 ► Randomise facilitators and participants
 ► Intervention facilitators only to be trained
 If there are organisational or setting constraints which 
prohibit facilitator or participant randomisation (eg, the 
facilitator works within a specified geographic location) 
we will assess whether there is ongoing contact between 
the facilitator and potential participants. In these 
scenarios: 
 ► Where there is ongoing contact (C)
 ► Train intervention facilitators only
 ► Randomise facilitators only
 ► Participants within each area allocated to facilitator 
(not randomised) 
 ► Where there is no ongoing contact (D)
 ► Train all facilitators
 ► Randomise participants
Participant flow through the study
Written informed consent will be collected from all 
participants and baseline data collected with a research 
team member (online or on paper, dependent on the 
participant preferences). Allocation will occur once the 
baseline assessment has been completed. Participants 
who are allocated to the intervention condition will be 
given access to the Genie intervention within 2 weeks of 
the baseline appointment; this process will be guided by 
Table 1 The factors affecting the recruitment and randomisation process  
Participant recruitment 
Contact between participant and facilitator 
Ongoing One-off contact (at facilitation) 
Area/location not restricted MODEL B
 ► Randomise facilitators and participants
 ► Intervention facilitators only to be trained
MODEL A
 ► Randomise facilitators and participants
 ► Intervention facilitators only to be trained
Within a specific geographical 
(or other prespecified) area
MODEL C
 ► Train intervention facilitators only
 ► Randomise facilitators only
 ► Participants within each area allocated to 
facilitator (not randomised)
MODEL D
 ► Train all facilitators
 ► Randomise participants
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the facilitator at a location to suit them (ie, at home or 
in the community). At 3 and 6 months after enrolment 
into the study, participants will be invited to complete 
follow-up assessments. All follow-up assessments will be 
recorded no earlier than 2 weeks before the follow-up 
date and no later than 6 weeks after the follow-up date. 
Each participant will be sent a £10 high street gift voucher 
with the 6-month follow-up questionnaire. Individuals 
allocated to the control group will be offered access to 
Genie with the facilitator after the have completed their 
6-month follow-up assessment. Participant flow is outlined 
in figure 1.
sample size consideration
The sample size calculation is based on the primary anal-
ysis of the comparison of intervention and control arms 
on SF-12 Mental Health composite scale (MCS) score at 
6 months,30 and accounts for possible intracluster correla-
tion (ICC) within facilitators. The MCS compares an indi-
vidual score with an age group mean score; a negative 
Figure 1 PALS study flow diagram. GENIE, Generating Engagement in Network Involvement; PALS, Project About Loneliness 
and Social networks.  
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score reflects poorer health. Previous studies (although 
in different populations) have suggested that differences 
of 3 and 4.7 points on the SF-12 would be clinically mean-
ingful.31 32 We have based the current sample size on 
being able to detect a difference of 4 points. Based on a 
previous study in socially isolated older people,33 we esti-
mate the SD of the outcome to be 10.4 (using a pooled 
estimate of baseline scores). Choosing 80% power and a 
type I error rate of 5%, an individually randomised study 
would require 216 people (108 per arm). Regarding clus-
tering, previous studies have generally shown low ICCs 
for mental health scores from SF-12 and SF-36 (0.032 and 
below, although for different populations and clustering 
within GP practices)33 34; we use an ICC of 0.05 here. 
Based on discussions with participating organisations, it 
was agreed that 12 participants per facilitator was suit-
able; this results in a design effect of 1.55 and an adjusted 
sample size of 335 people. Assuming 15% drop-out,35 
we require 394 participants in total (197 per arm). This 
requires 33 facilitators; we will increase this to 36 facilita-
tors to account for potential drop-out of facilitators.
the facilitated social network intervention
The intervention process is introduced initially via 
a guided discussion with a trained facilitator, takes 
30–40 min to deliver and has three stages: social network 
mapping, tailoring of preferences and linking users to 
valued resources and activities. By design, Genie (https:// 
pals. genie- net. org/ eng/), can be applied to varied 
user groups.27 It is based on evidence of social network 
properties and types, mechanisms and work relating to 
managing health and wellness.36–39 Previous testing of 
the principles has shown that it is both appropriate and 
acceptable to implement for individuals with a long-term 
condition.26–28
Facilitators
Guided facilitation is an important element of the guided 
process to using the tool. Facilitators do not need a 
specific in-depth theoretical knowledge: instead, the 
local knowledge of facilitators is important and adds to 
the value of the intervention. However, the interpersonal 
skills of the facilitator are vital for the success of engage-
ment through promoting a collaborative solution, and 
engaging participant focus, motivation and reflection on 
social network composition and promoting new commu-
nity engagement.27 Facilitators receive a minimum of a 
half-day training from the research team, which may be 
refreshed over the course of the study. This will include 
a background to, demonstration of and practical pair-
working exercises using video guides around the facilita-
tion process. Research methods training and discussion 
around loneliness and isolation are also addressed. The 
research team will provide ongoing support to monitor 
fidelity to the intervention deployment and address issues 
arising regarding complex cases (or facilitator difficulties 
and distress).
Social network mapping
Facilitators guide participants to create a visual map of 
their current support network, using a concentric circles 
method.27 The concentric circles process provides insight 
into the user’s current situation regarding social support; 
who they view as important in their daily lives (this may 
include family members, friends, acquaintances, health-
care professionals, local groups and pets); and then to 
reflect on renegotiating existing roles and responsibil-
ities, and further map people and groups who could 
provide extended support.26–28 This process, when guided 
by the facilitator, helps the participant to realign thinking 
about their relationships (and conceptualise themselves 
within a network of support), explore family dynamics 
and recognise ‘weak ties’ (ie, social acquaintances) that 
already exist in their network.27 It also offers the oppor-
tunity to begin discussions about how support may be 
extended within the network.
Linking individuals with preferences and valued local and online 
activities and resources
The next step involves facilitating access to local resources 
based on personal preferences, and acceptability to 
encourage engagement with personal choices, through 
a set of 13 questions.40 The questions generate a set of 
preferred local and online resources (linked to a prec-
reated database of categorised local organisations and 
resources). The facilitated discussion of preferences is 
linked to available and accepted potential support from 
people in a person’s network. Personalised results are 
presented in a user-friendly way aided by Google maps 
with clear details about access. Previous work has high-
lighted that this is often new and previously unthought 
about information for participants.27 The network maps, 
description of individual networks, preferences and the 
local and online resources identified as relevant by indi-
viduals can be printed to keep or reaccessed online later 
via a personalised Genie page.40 41 Two weeks after the 
intervention, all Genie users receive a phone call from 
the facilitator and alternative or additional engagement 
activities are discussed. The follow-up call takes up to 
10–15 min.
Wait-list control group
All participants allocated to the control group will be 
offered the opportunity to use the Genie intervention 
with a facilitator once the 6-month follow-up has been 
completed to avoid increasing inequalities as a result of 
the study, particularly for participants living in marginal-
ised and deprived domestic situations.
Patient and public involvement
Several of our partner organisations were involved in 
the development of the study and protocol, particularly 
contributing to understanding methodological issues 
around identifying participants. We will continue to 
work closely with all stakeholders in a pragmatic and 
flexible way to assess implementation issues throughout 
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the study. Patient and public involvement (PPI) repre-
sentatives were consulted in the development phase 
of the study, as well as discussion with the CLAHRC 
Wessex Wiserd group, and prior Genie engagement 
work. In addition, further PPI representatives have 
been included in the trial management group, and we 
have consulted with the user-led McPin organisation, 
who are represented on our Steering committee. We 
will involve our PPI representatives in the interpreta-
tion of the findings from our studies, particularly those 
of user views.
outcomes
The primary outcome of the trial will be the SF-12 
MCS score at 6-month follow-up between the interven-
tion and control group using a mixed-effects model 
(accounting for clustering within facilitators and 
organisation).
Secondary outcomes will include
 ► SF-12 MCS score between the intervention and control 
group at 3-month follow-up.
 ► SF-12 Physical Health composite score between inter-
vention and control groups at 6-month follow-up.
 ► Loneliness between intervention and control groups 
at 3-month and 6-month follow-up measured using 
the De Jong Loneliness scale42 and the Campaign 
against loneliness measure.43
 ► Social isolation between intervention and control 
groups at 3-month and 6-month follow-up measured 
using the Duke Social Support index.44
 ► Well-being measured using Warwick Edinburgh 
Mental Well-being scale.45
 ► Participant engagement with new activities.
Economic evaluation measures will include
 ► Quality-adjusted life year (QALYs) (incremental 
QALYs) between intervention and control at 6 
months, with health-related quality of life calculated 
using the SF-6D utility algorithm (derived from SF-12 
data).46
 ► Incremental costs of public sector resource between 
intervention and control at 6 months.
 ► Cost utility (expressed in terms of cost/QALY and 
cost/year of sufficient capability).
 ► Capability well-being measured using the ICEpop 
CAPability Measure for Adults (ICECAP-A) scores 
between intervention and control at 6 months.47
Process evaluation measures will include
 ► Participant perceived collective efficacy measured 
using the Collective Efficacy in Networks Scale48 
and social support using the Social Provisions Scale 
(SPA).49
 ► Perceptions of loneliness measured using a modified 
version of the Brief Illness Perception questionnaire.50
Intervention group only
 ► Social network composition change measured using 
Genie social network mapping (intervention group 
only at 3 months).
study endpoints
At 3 and 6 months after enrolment in to the study, patients 
will be invited to complete follow-up assessments. They may 
do this independently or with the assistance of the facilitator 
or a research team member (which may include online, on 
paper or over the phone). All follow-up assessments will be 
recorded no earlier than 2 weeks before the follow-up date 
and no later than 6 weeks after the follow-up date.
Measures
See table 2 for full details of study measures.
statistical analysis
All analyses will emphasise estimation and CIs over hypoth-
esis testing, and will be conducted as intention-to-treat. 
Table 2 Measures and schedule of observations within the 
PALS study
Measure
Time point (month)
Baseline
3-month 
follow-up
6-month 
follow-up
Sociodemographic measures X
Patient self-report measures (both 
groups)
  SF-12 Mental Health X X X
  SF-12 Physical Health X X X
  Loneliness (De Jong Scale) X X X
  Social isolation (Duke Social 
Support index)
X X X
  Campaign to End Loneliness 
scale
X X X
  Collective Efficacy in Networks 
Scale (CENS)
X X X
  Social support (SPA) X X X
  Warwick Edinburgh Mental 
Well-Being Scale (SWEMWBS)
X X X
  Perceptions of loneliness 
(modified B-IPQ)
X X X
  Participant engagement with 
new activities
X X X
Patient measures (network 
mapping, intervention group only)
  Social network composition 
change
X X
Economic measures
  SF-6D X X X 
  Capability well-being 
(ICECAP-A)
X X X
  Health and social care use X X X 
Process evaluation
  Qualitative interviews with 
participants
X X X
  Qualitative interviews with 
facilitators and stakeholders
X X X
  Observations of facilitation X
  Community staff observations 
of impact
X X X
PALS, Project About Loneliness and Social networks. 
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Missing data will be assumed to be missing at random, 
unless accounting for more than 10% of the sample; if 
missingness is above this rate, approaches for dealing with 
missing data (eg, multiple imputation) will be discussed 
within the research team. Missingness will be reported 
for each arm and summaries of baseline characteristics of 
those lost to follow-up and those not will be used to judge 
potential sources of bias.
Baseline sociodemographic data will be summarised 
within randomised arms using appropriate descrip-
tive measures; likewise, all outcome measures will be 
summarised by arm at each timepoint. We will produce 
a forest plot of estimated effects for each outcome within 
each organisation to explore any variability in the impact 
of the intervention.
The primary analysis will involve a mixed-effects model 
(pending the model meeting the associated assumptions) 
comparing groups on SF-12 at 6 months. The model will 
include a random intercept for facilitator and organisa-
tion, with participants clustered within facilitators clus-
tered within organisation (hence a three-level model) 
and control for baseline SF-12. This analysis will be 
complemented by an analysis using the same framework 
but with SF-12 as the outcome and a random coefficient 
for time, where repeated measurements are clustered 
within participants (hence a four-level model).
Non-response bias (ie, where a particular group of 
participants are unavailable or refuse to participate) will 
be reduced by taking steps to increase the initial response 
rate and reduce drop-out over the course of the study.
Economic analysis
The primary analysis will be a cost-utility analysis from 
a public sector perspective, with a primary outcome of 
cost/QALY at 6 months. Health-related quality of life 
will be collected via SF-12 at baseline, 3 and 6 months, 
with utilities being derived by application of the SF-6D 
scoring algorithm.46 In addition, scored values from the 
capability well-being measure (ICECAP-A)47 51 will enable 
a secondary cost-utility analysis.47 The use of ICECAP–A 
is planned to explore non-health attributes (specifically 
capabilities) that might be important to this population, 
thus allowing for a broader measurement of well-being 
than might be captured by SF-6D. While the compara-
tive data collected on both measures may inform future 
studies in similar populations, it will also provide deci-
sion-makers with richer information than would be 
obtained by a single generic Health realted Quality of 
Life (HRQoL) measure.
Intervention delivery resource use will be recorded 
on proformas designed to capture cost categories (eg, 
trainer time, pay scale, intervention setting and facilitator 
travel costs). Additionally, at baseline, 3 and 6 months 
resource use will be collected directly from participants 
using a questionnaire designed to capture healthcare, 
social service and other public sector service use, as well 
as participant service use (ie, participant and carer costs). 
An exploratory analysis will use a societal perspective 
providing decision-makers with evidence to inform 
judgements on what, in the broadest sense, is optimal 
for society.52 The analysis of costs from a societal perspec-
tive will therefore provide detail on the cost-shifts within 
sectors (eg, health compared with social care). All anal-
yses will follow practice guidelines,53–55 including those 
related to public health and/or complex interventions 
specifically.56–58 Cost-utility analysis will also allow for the 
construction of cost-effectiveness acceptability curves to 
assess whether the intervention is cost-effective at a range 
of payer thresholds.59 Subgroup analysis will be carried 
out in order to inform policy-makers’ decision-making 
with respect to the targeting of the intervention. Such 
subgroup analyses (for instance, looking at intervention 
effects in different groups) will be planned prospec-
tively, and quantitative analysis —foreseeably including 
mixed-effects modelling to account for the clustered 
nature of the data60 —will be set out as part of the statis-
tical and health economic analysis plan. The economic 
evaluation will also be informed by the process evaluation 
in terms of considering how the contexts of this complex 
intervention relate to resource use and cost areas.61 Such 
an explanatory focus will be taken throughout the study, 
with a view to interpreting study results and assessing 
study generalisability.
Qualitative process evaluation and analysis
The qualitative process evaluation will combine comple-
mentary components to seek to provide an in-depth 
understanding of the factors that facilitate individual, 
environmental and organisational factors that inhibit or 
promote the engagement, workability, integration, sustain-
ability and scalability of a social network intervention for 
addressing loneliness in open settings. The process eval-
uation will consider the preimplementation contexts and 
processes, as well as observing use of the intervention in 
practice to understand the dynamics of implementation 
(including how the facilitation and other elements work) 
to consider implications for scale-up and sustainability 
for the participating organisations. Concepts from the 
Consolidated Framework for Implementation Research62 
will be used to guide the identification of factors 
promoting or inhibiting the routine incorporation and 
embeddedness of a facilitated social network interven-
tion. The non-adoption, abandonment and challenges 
to the scale-up, spread and sustainability framework will 
inform the evaluation of implementation because it has 
been designed to help predict and evaluate the success 
of a technology-supported health programme, addressing 
concerns such as implementation, scale-up and sustain-
ability.63 An ethnographic approach making use of obser-
vations, interviews and documentary analysis will be used 
to capture the preimplementation processes in order 
to explore the workability and integration of Genie in 
different community organisations. Following this, inter-
views will take place to explore engagement, sustainability 
and scalability. Participants will be sampled purposively 
based on description of circumstances of loneliness and 
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sociodemographic factors (age, gender and locality); 
we will explore the experiences and meaning of loneli-
ness with reference to social and personal circumstances 
(eg, living and working arrangements) and situational 
contexts of loneliness (such as migration, separation 
and unemployment). This will be combined with explora-
tion of how individual circumstances shape engagement 
with different elements of the intervention, how change 
is enacted and embedded into people’s everyday lives and 
how this involves other members of a person’s network. 
We will describe the engagement and activities under-
taken following the intervention including how links with 
new networks and resources are identified and made 
(navigation); how these are integrated (negotiation) and 
how new connections improve capacity to enact healthy 
behaviours, improve well-being or reduce isolation 
(collective efficacy). We will explore how facilitators felt 
about delivering Genie and how this might be adopted by 
their organisations as part of their practice. We will draw 
out new improvements and benefits specific to individual 
circumstances and existing use of healthcare services. 
Further interviews postintervention will be conducted 
until ‘saturation’ (ie, no significant new insights emerge).
EthICs And dIssEMInAtIon
data monitoring
The Programme Steering Committee is responsible for 
ensuring programme adherence to the protocol, and 
adherence to the requirements of the Guidelines for 
Good Clinical Practice. The trial may be subject to inspec-
tion and audit by University of Southampton, under their 
remit as sponsor, the trial coordinating centre as the 
Sponsor’s delegate and other regulatory bodies.
dissemination
The findings from PALS will be disseminated widely 
through peer-reviewed publications, scientific conferences 
and workshops. In addition, we will aim to disseminate 
through multiple community pathways in collaboration 
with our partners and stakeholders (including local 
councils, NHS trusts and other local and national organ-
isations) through interactive methods, such as targeted 
workshops, podcasts or blogs. If successful, we aim to 
produce a user guide for applying Genie to loneliness 
and isolation.
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